Of the tracked stories, 3 of 4 also mention Wall Street Zen, the most common co-covered peer. Coverage clusters in markets, which accounts for 3 of those 4, with the remainder spread across 1 other category. Across a 37-day span, the pace is roughly 0.8 stories per week.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about B. Riley Financial
Of the tracked stories, 3 of 4 also mention Wall Street Zen, the most common co-covered peer. Coverage clusters in markets, which accounts for 3 of those 4, with the remainder spread across 1 other category. Across a 37-day span, the pace is roughly 0.8 stories per week. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window. The 5 average consequence score is below the beat benchmark of 5.7 in the same window. We currently track 4 Finance stories that mention B. Riley Financial, published between July 31, 2026 and September 5, 2026.
Stories tracked
4
Per week
0.8
Sources per story
2
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 776 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering B. Riley Financial. Shared-story counts are live from our verified record — not editorial picks.
Needham & Company reiterated Buy ratings on Salesforce (CRM) and Solaris Energy Infrastructure (SEI) with price targets of $400 and $98. CRM opened at $259.39, implying 54% upside, while SEI opened at $55.08, implying 78% upside. The ratings highlight divergent risk-reward profiles across software and energy infrastructure.
Wall Street Zen lifted Amplify Energy to Hold from Strong Sell on August 16, with shares at $4.78 and a $9 consensus target. Thin coverage and insider buying make the upgrade a key sentiment shift for a $198 million small-cap energy name.
In a single day, Wall Street Zen downgraded CME Group to strong sell, and Novavax and SNDL to sell, sending bearish signals across exchanges, biotech, and cannabis. Markets digest the calls amid wide analyst disagreement.
AXT blew past Q3 consensus with EPS guidance of $0.30-$0.32 vs. $0.10 and revenue of $66M vs. $38.7M, while Crocs missed with $3.20-$3.30 EPS vs. $3.55 and $996.3M revenue vs. $1.0B. The split paints a complex picture for investors, highlighting a semiconductor super-cycle amid softening consumer discretionary.